Eksigent, a developer of low-flow fluid delivery for drug discovery and life science applications, announces a distribution agreement with Separations Analytical Instruments, based in the Netherlands
The agreement covers sales of Eksigent's NanoLC HPLC product line in the Benelux region.
"Our NanoLC platform for proteomics applications has been well received in the US biotech and pharmaceutical industries as well as the academic community," commented David Weber, Eksigent's president and CEO.
"We have now expanded our marketing and management staff and we're well-positioned to serve the European academic, biotech and pharmaceutical markets".
Separations Analytical Instruments, founded in 1989, specialises in sales and service of HPLC and online SPE systems, representing a range of US and European-based manufacturers.
The company serves pharmaceutical, life science and environmental customers with special emphasis on high-throughput applications.
We are delighted to represent the Eksigent NanoLC product line," commented Rein Reitsma, sales manager for Separations Analytical.
"Eksigent systems are the most innovative and reliable NanoLC products we can offer to our customers in the Benelux region".
Eksigent is a pioneer in low-flow fluid delivery systems that automate and accelerate proteomics, drug discovery, drug delivery and other life science applications.
Eksigent's core technologies include microscale pumping, microfluidic system design and microfabrication.
The company offers solutions for nanoscale liquid chromatography, high-performance capillary liquid chromatography and drug delivery.
